Works about DOPAMINE analysis


Results: 187
    1
    2
    3
    4
    5
    6
    7
    8
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Endocannabinoid levels in plasma and neurotransmitters in the brain: a preliminary report on patients with a psychotic disorder and healthy individuals.

    Published in:
    Psychological Medicine, 2024, v. 54, n. 9, p. 2189, doi. 10.1017/S0033291724000291
    By:
    • van Hooijdonk, Carmen F. M.;
    • Balvers, Michiel G. J.;
    • van der Pluijm, Marieke;
    • Smith, Charlotte L. C.;
    • de Haan, Lieuwe;
    • Schrantee, Anouk;
    • Yaqub, Maqsood;
    • Witkamp, Renger F.;
    • van de Giessen, Elsmarieke;
    • van Amelsvoort, Therese A. M. J.;
    • Booij, Jan;
    • Selten, Jean-Paul
    Publication type:
    Article
    19
    20

    Linking unfounded beliefs to genetic dopamine availability.

    Published in:
    Frontiers in Human Neuroscience, 2015, v. 9, p. 1, doi. 10.3389/fnhum.2015.00521
    By:
    • Schmack, Katharina;
    • Rössler, Hannes;
    • Sekutowicz, Maria;
    • Brandl, Eva J.;
    • Müller, Daniel J.;
    • Petrovic, Predrag;
    • Sterzer, Philipp
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27

    A Mutation in Hnrnph1 That Decreases Methamphetamine-Induced Reinforcement, Reward, and Dopamine Release and Increases Synaptosomal hnRNP H and Mitochondrial Proteins.

    Published in:
    Journal of Neuroscience, 2020, v. 40, n. 1, p. 107, doi. 10.1523/JNEUROSCI.1808-19.2019
    By:
    • Ruan, Qiu T.;
    • Yazdani, Neema;
    • Blum, Benjamin C.;
    • Beierle, Jacob A.;
    • Weiwei Lin;
    • Coelho, Michal A.;
    • Fultz, Elissa K.;
    • Healy, Aidan F.;
    • Shahin, John R.;
    • Kandola, Amarpreet K.;
    • Luttik, Kimberly P.;
    • Karen Zheng;
    • Smith, Nathaniel J.;
    • Cheung, Justin;
    • Mortazavi, Farzad;
    • Apicco, Daniel J.;
    • Varman, Durairaj Ragu;
    • Ramamoorthy, Sammanda;
    • Ash, Peter E. A.;
    • Rosene, Douglas L.
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    A multimodal neuroimaging study of youth at risk for substance use disorders: Functional magnetic resonance imaging and [<sup>18</sup>F]fallypride positron emission tomography.

    Published in:
    Alcohol, Clinical & Experimental Research, 2025, v. 49, n. 2, p. 332, doi. 10.1111/acer.15511
    By:
    • Nikolic, Maja;
    • Cox, Sylvia M. L.;
    • Jaworska, Natalia;
    • Castellanos‐Ryan, Natalie;
    • Dagher, Alain;
    • Vitaro, Frank;
    • Brendgen, Mara;
    • Parent, Sophie;
    • Boivin, Michel;
    • Côté, Sylvana;
    • Tremblay, Richard E.;
    • Séguin, Jean R.;
    • Leyton, Marco
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50